Pillar3 Capacity Building
DA-EWG's capacity building activities have matured over time. Initially, it was necessary to conduct a stakeholder's needs analysis to promote mutual understanding of critical capacity for drug discovery and investment priorities of each country as well as to build the trust needed to develop an open innovation platform. Considering feedbacks from this analysis, DA-EWG's capacity building activities have tried to promote information sharing among government, academia and industry on best practices to develop drug discovery capacity through open innovation. Events include presentations from thought leaders in Asia and panel discussions that can allow the audience to interact and learn from the experiences of other economies at Asian Bio-conferences (see pictures below).